BioReference Direct reflects a broader shift toward more accessible, consumer-driven healthcare, where diagnostics play a central role in enabling earlier insights, informed decisions, and ongoing ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
ELMWOOD PARK, N.J., April 27, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its renewal as the COVID-19 testing provider for Major League Soccer ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So What: ...
Similar to BioReference's role as the testing provider for the MLS is Back Tournament, BioReference is providing laboratory-based PCR COVID-19 testing as well as point-of-care (rapid) COVID-19 testing ...
BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...
Scarlet brings diagnostic service to patients' homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ...
ELMWOOD PARK, N.J., Dec. 12, 2017 /PRNewswire/ -- BioReference Laboratories, Inc., one of the nation's largest, full-service clinical diagnostic laboratories, applauds the American Clinical Laboratory ...
) announced today that it completed the acquisition of a clinical laboratory in northern California. The Company believes that the California acquisition represents significant strategic value to its ...
ELMWOOD PARK, N.J., Aug. 16, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S ...
BioReference Health, formerly known as BioReference Laboratories, and OPKO Health have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act arising from BioReference’s ...
One day after 11 NFL teams experienced false positive COVID-19 tests of players, coaches and staff stemming from a contamination in a New Jersey testing laboratory, BioReference Laboratories issued a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results